Code | 3332D | ||||||||||
MA number | EU/1/19/1358/003 | ||||||||||
Product Form: | sol inj 1x1,5 ml/225 mg (pero inj.napl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | TEVA GmbH, Germany | ||||||||||
Therapeutic Class: | 33 - ANTIMIGRAENICA,ANTISEROTONICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 28.03.2019 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 20.11.2023 |